ATA727279A - Verfahren zur herstellung von neuen cephalosporin-antibiotika - Google Patents

Verfahren zur herstellung von neuen cephalosporin-antibiotika

Info

Publication number
ATA727279A
ATA727279A AT0727279A AT727279A ATA727279A AT A727279 A ATA727279 A AT A727279A AT 0727279 A AT0727279 A AT 0727279A AT 727279 A AT727279 A AT 727279A AT A727279 A ATA727279 A AT A727279A
Authority
AT
Austria
Prior art keywords
producing new
antibiotics
new cephalosporine
cephalosporine antibiotics
producing
Prior art date
Application number
AT0727279A
Other languages
English (en)
Other versions
AT366387B (de
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to AT0200281A priority Critical patent/AT371124B/de
Priority to AT0200381A priority patent/AT373894B/de
Publication of ATA727279A publication Critical patent/ATA727279A/de
Application granted granted Critical
Publication of AT366387B publication Critical patent/AT366387B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
AT0727279A 1978-11-15 1979-11-14 Verfahren zur herstellung von neuen cephalosporin-antibiotika AT366387B (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AT0200281A AT371124B (de) 1978-11-15 1981-05-06 Verfahren zur herstellung von neuen cephalosporin-antibiotika
AT0200381A AT373894B (de) 1978-11-15 1981-05-06 Verfahren zur herstellung von neuen cephalosporin-antibiotika sowie von deren salzen und estern

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7844595 1978-11-15
GB7844597 1978-11-15

Publications (2)

Publication Number Publication Date
ATA727279A true ATA727279A (de) 1981-08-15
AT366387B AT366387B (de) 1982-04-13

Family

ID=26269583

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0727279A AT366387B (de) 1978-11-15 1979-11-14 Verfahren zur herstellung von neuen cephalosporin-antibiotika

Country Status (17)

Country Link
US (1) US4464368A (de)
AT (1) AT366387B (de)
AU (1) AU529825B2 (de)
CA (1) CA1136616A (de)
CH (1) CH647784A5 (de)
DE (1) DE2946038A1 (de)
DK (1) DK480679A (de)
ES (3) ES485937A1 (de)
FI (1) FI793566A (de)
FR (1) FR2441630A1 (de)
IE (1) IE49207B1 (de)
IL (1) IL58717A (de)
LU (1) LU81884A1 (de)
NL (1) NL7908318A (de)
NO (1) NO793688L (de)
NZ (1) NZ192127A (de)
SE (1) SE7909401L (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR78245B (de) * 1980-09-12 1984-09-26 Ciba Geigy Ag
NZ198350A (en) * 1980-09-25 1985-02-28 Toyama Chemical Co Ltd Cephalosporins and intermediates;pharmaceutical compositions
EP0062321B1 (de) * 1981-04-03 1989-03-01 Fujisawa Pharmaceutical Co., Ltd. Cephalosporinderivate, Verfahren zu ihrer Herstellung, sie enthaltende pharmazeutische Präparate und ihre Ausgangsprodukte
DE3336757A1 (de) * 1983-10-08 1985-04-25 Hoechst Ag, 6230 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
CN86107947A (zh) * 1985-11-22 1987-05-27 藤沢药品工业株式会社 新的头孢烯化合物及其制备方法
US5373000A (en) * 1985-12-26 1994-12-13 Eisai Co., Ltd. 7Beta-(thiadiazolyl)-2-iminoacetamido-3cephem compounds
ATE92927T1 (de) * 1986-04-14 1993-08-15 Banyu Pharma Co Ltd 1-carboxy-1-vinyloxyiminoaminothiazolcephalosporin-derivate und deren herstellung.
GB8611823D0 (en) * 1986-05-15 1986-06-25 Ici Plc Process
US5162520A (en) * 1986-09-22 1992-11-10 Fujisawa Pharmaceutical Co., Ltd. Intermediates for cephem compounds
CA1293719C (en) * 1986-09-22 1991-12-31 Takao Takaya Cephem compounds and processes for preparation thereof
US5624898A (en) 1989-12-05 1997-04-29 Ramsey Foundation Method for administering neurologic agents to the brain
US6407061B1 (en) 1989-12-05 2002-06-18 Chiron Corporation Method for administering insulin-like growth factor to the brain
WO2016028670A1 (en) * 2014-08-18 2016-02-25 Merck Sharp & Dohme Corp. Salt forms of ceftolozane
WO2016109259A2 (en) 2014-12-30 2016-07-07 Merck Sharp & Dohme Corp. Synthesis of cephalosporin compounds

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024133A (en) * 1971-05-14 1977-05-17 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(thienyl-,furyl- or pyridylacetamido)]cephalosporins
US4092477A (en) * 1971-05-14 1978-05-30 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(phenyl- or naphthylacetamido)] cephalosporins
US4093803A (en) * 1971-05-14 1978-06-06 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(thienyl-, furyl- or pyridylacetamido)] cephalosporins
US3971778A (en) * 1972-05-12 1976-07-27 Glaxo Laboratories Limited Cephalosporins having (α-etherified oximino)acylamido groups at the 7-position
US4079178A (en) * 1971-05-14 1978-03-14 Glaxo Laboratories Limited Cephalosporins having (α-etherified oximino) acylamido groups at the 7-position
US4017515A (en) * 1971-05-14 1977-04-12 Glaxo Laboratories Limited α-(Etherified oximino) carboxylic acids and acid chlorides
US4024137A (en) * 1971-05-14 1977-05-17 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(phenyl- or naphthylacetamido)] cephalosporins
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
US4064346A (en) * 1971-05-14 1977-12-20 Glaxo Laboratories Limited 3-Acetoxymethyl-7β-(2-carboxy-methoxyimino-2-arylacetamido)ceph-3-em-4-carboxylic acids and salts thereof
US4144392A (en) * 1973-12-21 1979-03-13 Glaxo Laboratories Limited Cephalosporins having at position-7 a carboxy substituted α-etherified hydroxyimino-arylacetamido group and at position-3 the residue of a sulphur nucleophile
GB1496757A (en) * 1973-12-21 1978-01-05 Glaxo Lab Ltd Cephalosporin derivatives
US4095021A (en) * 1973-12-21 1978-06-13 Glaxo Laboratories Limited 3-Carbamoyloxymethyl or N-methyl-carbamoyloxymethyl-7-[2-carboxymethoxyimino-2-(fur-2-yl or thien-2-yl)acetamido]ceph-3-em-4-carboxylic acids and derivatives thereof
US4162360A (en) * 1973-12-21 1979-07-24 Glaxo Laboratories Limited 3-Carbamoyloxymethyl-7-substituted oximino acetamido cephalosporanic acid derivatives
US4060686A (en) * 1973-12-21 1977-11-29 Janice Bradshaw Cephalosporins having a 7-(carboxy substituted α-etherified oximinoarylacetamido) group
US4032950A (en) * 1974-12-06 1977-06-28 Hughes Aircraft Company Liquid phase epitaxial process for growing semi-insulating gaas layers
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
US4165430A (en) * 1976-03-19 1979-08-21 Glaxo Laboratories Limited Cephalosporins having a 7-carboxy substituted α-etherified oximinoarylacetamido) group
US4166115A (en) * 1976-04-12 1979-08-28 Fujisawa Pharmaceutical Co., Ltd. Syn 7-oxoimino substituted derivatives of cephalosporanic acid
FR2457296A1 (fr) * 1979-05-23 1980-12-19 Rhone Poulenc Ind Nouveaux derives de vinyl-3 cephalosporines et leur preparation
IL61458A0 (en) * 1979-12-07 1980-12-31 Erba Farmitalia N-substituted thiazolyl derivatives of oximino-substituted cephalosporins, their preparation and pharmalceutical compositions containing them
US4382932A (en) * 1981-09-08 1983-05-10 Eli Lilly And Company Isoquinolinium substituted cephalosporins

Also Published As

Publication number Publication date
ES485939A1 (es) 1980-07-01
NL7908318A (nl) 1980-05-19
IL58717A0 (en) 1980-02-29
IE792186L (en) 1980-05-15
SE7909401L (sv) 1980-05-16
DK480679A (da) 1980-05-16
CA1136616A (en) 1982-11-30
NO793688L (no) 1980-05-19
DE2946038A1 (de) 1980-05-29
FR2441630A1 (fr) 1980-06-13
US4464368A (en) 1984-08-07
LU81884A1 (fr) 1980-06-05
FI793566A (fi) 1980-05-16
IE49207B1 (en) 1985-08-21
AU529825B2 (en) 1983-06-23
IL58717A (en) 1983-05-15
NZ192127A (en) 1982-12-21
ES485938A1 (es) 1980-07-01
FR2441630B1 (de) 1983-06-03
CH647784A5 (de) 1985-02-15
AT366387B (de) 1982-04-13
ES485937A1 (es) 1980-07-01
AU5281579A (en) 1980-05-22

Similar Documents

Publication Publication Date Title
ATA239281A (de) Verfahren zur herstellung von neuen cephalosporin-antibiotika
AT368161B (de) Verfahren zur herstellung von neuen cephalosporin-antibiotika
AT369381B (de) Verfahren zur herstellung von neuen cephalosporin-antibiotika
AT366387B (de) Verfahren zur herstellung von neuen cephalosporin-antibiotika
AT376684B (de) Verfahren zur herstellung von neuen bor-silicium- verbindungen
AT369009B (de) Verfahren zur herstellung von neuen cephalosporin-antibiotika
AT367766B (de) Verfahren zur herstellung von neuen cephalosporin-antibiotika
AT362872B (de) Verfahren zur herstellung von neuen demethylmaytansinoiden
AT367765B (de) Verfahren zur herstellung von neuen cephalosporin-antibiotika
AT368516B (de) Verfahren zur herstellung von neuen nitrosoharnstoff-verbindungen
AT364347B (de) Verfahren zur herstellung von neuen 1beta-hydroxy-2beta-alkenyl-3-methylencyclopentan-4 beta-yl-cyclopropancarboxylaten
AT365597B (de) Verfahren zur herstellung von neuen cephalosporin-antibiotika
AT365196B (de) Verfahren zur herstellung von neuen cephalosporin-verbindungen
AT365195B (de) Verfahren zur herstellung von neuen cephalosporin-verbindungen
AT366385B (de) Verfahren zur herstellung von neuen penicillinverbindungen
AT368517B (de) Verfahren zur herstellung von neuen nitrosoharnstoffverbindungen
AT362067B (de) Verfahren zur herstellung von neuen deoxyanthracyclinen
AT371124B (de) Verfahren zur herstellung von neuen cephalosporin-antibiotika
AT365600B (de) Verfahren zur herstellung von neuen cephalosporin-antibiotika
ATA330781A (de) Verfahren zur herstellung von neuen cephalosporin-antibiotika
AT372385B (de) Verfahren zur herstellung von neuen cephalosporin-antibiotika
AT369007B (de) Verfahren zur herstellung von neuen cephalosporin-derivaten
ATA110381A (de) Verfahren zur herstellung von neuen spirobenzofuranonverbindungen
ATA352382A (de) Verfahren zur herstellung von neuen n-oxacyclyl-alkyl-piperidyl-diazaverbindungen
ATA218481A (de) Verfahren zur herstellung von neuen 3-phosphonocarbamoyloxymethylcephalosporinverbindungen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee